Evidence map›Paper›PMID 41897283›Full record

ArticleBiomolecules2026

Targeting G9a Exerts Pleiotropic Suppression in Triple-Negative Breast Cancer Cells: Cooperatively Inducing Pyroptosis and Apoptosis.

Jialin Li, Guijuan Zhang, Tianyang Liu, Xianxin Yan, Min Ma

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jialin LiThe First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China.
Guijuan ZhangSchool of Nursing, Jinan University, Guangzhou 510632, China.
Tianyang LiuSchool of Traditional Chinese Medicine, Jinan University, No. 601, West Huangpu Avenue, Guangzhou 510632, China.
Xianxin YanThe First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China.
Min MaThe First School of Clinical Medicine, State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Jinan University, Guangzhou 510632, China.

Funding

National Natural Science Foundation of China 82074430 and 81803979
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Molecular Targeted TherapyPyroptosisRNA, Small InterferingTriple Negative Breast NeoplasmsDEAD Box Protein 58GasderminsGene Knockdown TechniquesGenetic PleiotropyHistocompatibility AntigensHistone-Lysine N-MethyltransferaseMDA-MB-231 CellsReceptors, ImmunologicSTAT1 Transcription FactorDEAD Box Protein 58EHMT2 protein, humanGasderminsGSDME protein, humanHistocompatibility AntigensHistone-Lysine N-MethyltransferaseReceptors, ImmunologicRIGI protein, humanRNA, Small InterferingSTAT1 protein, humanSTAT1 Transcription FactorBIX-01294G9apyroptosisRIG-I/STAT1/GSDMEtriple-negative breast cancer

Identifiers

PMID41897283
PMCPMC13023577

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.